PD-L1 targets the cell line in A375 melanoma cells transfected with the human PD-L1 gene, whereas the FAP targets are notorious for being ubiquitous in tumor cells, and several clinical trials are underway regarding the diagnostic results of using these two markers [19]. This evidence concerns the gene FAP and neoplasm.